205 related articles for article (PubMed ID: 29156726)
1. Adiponectin receptor agonists inhibit leptin induced pSTAT3 and
Messaggio F; Mendonsa AM; Castellanos J; Nagathihalli NS; Gorden L; Merchant NB; VanSaun MN
Oncotarget; 2017 Oct; 8(49):85378-85391. PubMed ID: 29156726
[TBL] [Abstract][Full Text] [Related]
2. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
Wu X; Yan Q; Zhang Z; Du G; Wan X
Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
[TBL] [Abstract][Full Text] [Related]
3. Globular adiponectin inhibits leptin-stimulated esophageal adenocarcinoma cell proliferation via adiponectin receptor 2-mediated suppression of UHRF1.
Wang J; Cheng Y; Yin X; Wu J; Luo Y; Wu J; Di J; Liu D; Huang Y; Zhang R; Zhang J
Mol Cell Biochem; 2017 Jul; 431(1-2):103-112. PubMed ID: 28285359
[TBL] [Abstract][Full Text] [Related]
4. Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice.
Wang Y; Wan Y; Ye G; Wang P; Xue X; Wu G; Ye B
Eur J Pharm Sci; 2016 Oct; 93():123-31. PubMed ID: 27516150
[TBL] [Abstract][Full Text] [Related]
5. Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells.
Manley SJ; Olou AA; Jack JL; Ruckert MT; Walsh RM; Eades AE; Bye BA; Ambrose J; Messaggio F; Anant S; VanSaun MN
Cell Death Dis; 2022 Feb; 13(2):114. PubMed ID: 35121743
[TBL] [Abstract][Full Text] [Related]
6. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
[TBL] [Abstract][Full Text] [Related]
7. [Adiponectin Receptor Agonist AdipoRon Inhibits the Proliferation of Myeloma Cells via the AMPK/Autophagy Pathway].
Wang SJ; Wang C; Wang WQ; Hao QQ; Liu YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):171-176. PubMed ID: 32027272
[TBL] [Abstract][Full Text] [Related]
8. AdipoRon may be benefit for atherosclerosis prevention.
Esfahani M; Shabab N; Saidijam M
Iran J Basic Med Sci; 2017 Feb; 20(2):107-109. PubMed ID: 28293385
[TBL] [Abstract][Full Text] [Related]
9. AdipoRon negatively regulates proliferation and migration of ARPE-19 human retinal pigment epithelial cells.
Mallardo M; Costagliola C; Nigro E; Daniele A
Peptides; 2021 Dec; 146():170676. PubMed ID: 34687793
[TBL] [Abstract][Full Text] [Related]
10. AdipoRon: a possible drug for colorectal cancer prevention?
Malih S; Najafi R
Tumour Biol; 2015 Sep; 36(9):6673-5. PubMed ID: 26282004
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin receptor-1 expression is decreased in the pancreas of obese mice.
Wade TE; Mathur A; Lu D; Swartz-Basile DA; Pitt HA; Zyromski NJ
J Surg Res; 2009 Jun; 154(1):78-84. PubMed ID: 19062045
[TBL] [Abstract][Full Text] [Related]
12. The adiponectin receptor agonist AdipoRon normalizes glucose metabolism and prevents obesity but not growth retardation induced by glucocorticoids in young mice.
Nicolas S; Rochet N; Gautier N; Chabry J; Pisani DF
Metabolism; 2020 Feb; 103():154027. PubMed ID: 31778708
[TBL] [Abstract][Full Text] [Related]
13. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells.
Xin XM; Zhong MX; Yang GL; Peng Y; Zhang YL; Zhu W
World J Gastroenterol; 2014 Nov; 20(42):15727-35. PubMed ID: 25400456
[TBL] [Abstract][Full Text] [Related]
14. [Serum adipokines and their receptors in endometrial and colon cancer patients: relationship with tumor invasion and metastasis].
Yunusova NV; Kondakova IV; Kolomiets LA; S G Afanasiev ; Chernyshova AL; Shatokhina OV; Frolova AE; Zhou Z; Wang W
Vopr Onkol; 2015; 61(4):619-23. PubMed ID: 26571833
[TBL] [Abstract][Full Text] [Related]
15. Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice.
Takenaga K; Akimoto M; Koshikawa N; Nagase H
Sci Rep; 2021 Feb; 11(1):2923. PubMed ID: 33536560
[TBL] [Abstract][Full Text] [Related]
16. Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival.
Babic A; Wang QL; Lee AA; Yuan C; Rifai N; Luo J; Tabung FK; Shadyab AH; Wactawski-Wende J; Saquib N; Kim J; Kraft P; Sesso HD; Buring JE; Giovannucci EL; Manson JE; Stampfer MJ; Ng K; Fuchs CS; Wolpin BM
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1458-1469. PubMed ID: 37555827
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma Growth.
Nguyen MLT; Pham C; Pham VT; Nham PLT; Ta BT; Le DT; Le QV; Hoang XC; Bozko P; Nguyen LT; Bui KC
Cell Biochem Biophys; 2024 Jan; ():. PubMed ID: 38243102
[TBL] [Abstract][Full Text] [Related]
18. Differential adipokine receptor expression on circulating leukocyte subsets in lean and obese children.
Keustermans G; van der Heijden LB; Boer B; Scholman R; Nuboer R; Pasterkamp G; Prakken B; de Jager W; Kalkhoven E; Janse AJ; Schipper HS
PLoS One; 2017; 12(10):e0187068. PubMed ID: 29073286
[TBL] [Abstract][Full Text] [Related]
19. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin and adiponectin receptor in relation to colorectal cancer progression.
Byeon JS; Jeong JY; Kim MJ; Lee SM; Nam WH; Myung SJ; Kim JG; Yang SK; Kim JH; Suh DJ
Int J Cancer; 2010 Dec; 127(12):2758-67. PubMed ID: 21351255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
